Alison Yeggy, in Shelbyville, KY - Medicare Occupational Therapy Provider

Alison Yeggy, is a medicare enrolled "Occupational Therapist" provider in Shelbyville, Kentucky. She graduated from medical school in 2017 and has 7 years of diverse experience with area of expertise as Occupational Therapy. She is a member of the group practice Hearing Speech And Deaf Center Of Greater Cincinnati and her current practice location is 90 Howard Dr, Shelbyville, Kentucky. You can reach out to her office (for appointments etc.) via phone at (502) 633-1007.

Alison Yeggy is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1033616263.

Contact Information

	Alison Yeggy,
	90 Howard Dr, Shelbyville, KY 40065
	(502) 633-1007
	Not Available

Healthcare Provider's Profile

Full Name	Alison Yeggy
Gender	Female
Speciality	Occupational Therapy
Experience	7 Years
Location	90 Howard Dr, Shelbyville, Kentucky
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Alison Yeggy graduated from medical school in 2017

NPI Data:

NPI Number: 1033616263
Provider Enumeration Date: 04/13/2018
Last Update Date: 12/16/2019

Medicare PECOS Information:

PECOS PAC ID: 2163785304
Enrollment ID: I20180420001873

Medical Identifiers

Medical identifiers for Alison Yeggy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033616263	NPI	-	NPPES
OT010139	Other		LICENSE NUMBER

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	(* (Not Available))	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Hearing Speech And Deaf Center Of Greater Cincinnati	6103845466	8

News Archive

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients with amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

Unusual protein helps cell bypass damage when making new DNA

Scientists have discovered how an unusual protein helps a cell bypass damage when making new DNA, thereby averting the cell's self-destruction.

Race, ethnicity, and insurance status influence follow-up care

According to the results of a new study published in the Journal of the American College of Surgeons, African-Americans, Hispanics and uninsured patients use fewer post-hospitalization services after traumatic injury, including home health care, skilled nursing care, and rehabilitation.

Critical care journal editors release joint statement affirming commitment to ethical conduct of research

In response to an announcement by the German State Medical Association of Rheinland-Pfalz of their initial review of more than 100 articles by Professor Joachim Boldt, Steven L. Shafer, MD, Editor-in-Chief of Anesthesia & Analgesia, has joined with ten other anesthesiology and critical care journal editors in releasing a joint statement affirming their commitment to ethical conduct of research.

Positive interventions in sepsis management raise key questions about E. coli reduction targets

Sepsis detection success raises important questions about E. coli reduction targets

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Alison Yeggy allows following entities to bill medicare on her behalf.

Provider Name	Hearing Speech And Deaf Center Of Greater Cincinnati
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1083667497 PECOS PAC ID: 6103845466 Enrollment ID: O20051221000472

News Archive

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Unusual protein helps cell bypass damage when making new DNA

Scientists have discovered how an unusual protein helps a cell bypass damage when making new DNA, thereby averting the cell's self-destruction.

Race, ethnicity, and insurance status influence follow-up care

Critical care journal editors release joint statement affirming commitment to ethical conduct of research

Positive interventions in sepsis management raise key questions about E. coli reduction targets

Sepsis detection success raises important questions about E. coli reduction targets

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alison Yeggy is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alison Yeggy, 3742 Darwin Ave, Cincinnati, OH 45211-5404 Ph: (513) 328-8189	Alison Yeggy, 90 Howard Dr, Shelbyville, KY 40065 Ph: (502) 633-1007

News Archive

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Unusual protein helps cell bypass damage when making new DNA

Scientists have discovered how an unusual protein helps a cell bypass damage when making new DNA, thereby averting the cell's self-destruction.

Race, ethnicity, and insurance status influence follow-up care

Critical care journal editors release joint statement affirming commitment to ethical conduct of research

Positive interventions in sepsis management raise key questions about E. coli reduction targets

Sepsis detection success raises important questions about E. coli reduction targets

Occupational Therapist in Shelbyville, KY

Katie Flanigan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Midland Trl, Suite 1 And 2, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-805-1511
Kayleigh Hinton Talbott, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007
Michelle Vogt Smith, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 Midland Trl, Suite 1 And 2, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-805-1511
Anna Nicole Perlack, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007
Hillary Forsee, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-805-1511
Kathryn Mary Noonan, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 90 Howard Dr, Shelbyville, KY 40065 Phone: 502-633-1007 Fax: 502-437-0624

Alison Yeggy, - Medicare Occupational Therapist in Shelbyville, KY

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Unusual protein helps cell bypass damage when making new DNA

Race, ethnicity, and insurance status influence follow-up care

Critical care journal editors release joint statement affirming commitment to ethical conduct of research

Positive interventions in sepsis management raise key questions about E. coli reduction targets

Medicare Reassignments

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Unusual protein helps cell bypass damage when making new DNA

Race, ethnicity, and insurance status influence follow-up care

Critical care journal editors release joint statement affirming commitment to ethical conduct of research

Positive interventions in sepsis management raise key questions about E. coli reduction targets

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Aquinnah Pharmaceuticals wins NINDS grant to advance novel therapies for ALS

Unusual protein helps cell bypass damage when making new DNA

Race, ethnicity, and insurance status influence follow-up care

Critical care journal editors release joint statement affirming commitment to ethical conduct of research

Positive interventions in sepsis management raise key questions about E. coli reduction targets

Occupational Therapist in Shelbyville, KY